1. Home
  2. DFLI vs CTXR Comparison

DFLI vs CTXR Comparison

Compare DFLI & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DFLI
  • CTXR
  • Stock Information
  • Founded
  • DFLI 2020
  • CTXR 2007
  • Country
  • DFLI United States
  • CTXR United States
  • Employees
  • DFLI N/A
  • CTXR N/A
  • Industry
  • DFLI Electronic Components
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • DFLI Technology
  • CTXR Health Care
  • Exchange
  • DFLI Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • DFLI 5.0M
  • CTXR 14.6M
  • IPO Year
  • DFLI N/A
  • CTXR N/A
  • Fundamental
  • Price
  • DFLI $0.54
  • CTXR $0.85
  • Analyst Decision
  • DFLI Strong Buy
  • CTXR Strong Buy
  • Analyst Count
  • DFLI 4
  • CTXR 2
  • Target Price
  • DFLI $12.83
  • CTXR $54.50
  • AVG Volume (30 Days)
  • DFLI 265.0K
  • CTXR 683.7K
  • Earning Date
  • DFLI 05-13-2025
  • CTXR 05-13-2025
  • Dividend Yield
  • DFLI N/A
  • CTXR N/A
  • EPS Growth
  • DFLI N/A
  • CTXR N/A
  • EPS
  • DFLI N/A
  • CTXR N/A
  • Revenue
  • DFLI $50,645,000.00
  • CTXR N/A
  • Revenue This Year
  • DFLI $42.48
  • CTXR N/A
  • Revenue Next Year
  • DFLI $42.95
  • CTXR N/A
  • P/E Ratio
  • DFLI N/A
  • CTXR N/A
  • Revenue Growth
  • DFLI N/A
  • CTXR N/A
  • 52 Week Low
  • DFLI $0.46
  • CTXR $0.80
  • 52 Week High
  • DFLI $13.14
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • DFLI 24.41
  • CTXR 30.35
  • Support Level
  • DFLI $0.46
  • CTXR $0.80
  • Resistance Level
  • DFLI $0.67
  • CTXR $1.02
  • Average True Range (ATR)
  • DFLI 0.09
  • CTXR 0.08
  • MACD
  • DFLI 0.02
  • CTXR 0.02
  • Stochastic Oscillator
  • DFLI 16.10
  • CTXR 16.33

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a highly cost-effective storage solution.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: